BridgeMD
New treatment option for Neoplasm
Official title CARE Study: Cancer, Asian Americans, and Relationship Enrichment
ClinicalTrials.gov ID: NCT06782581
What this study is testing
- What it's testing
- The overarching goal of the current study is to reduce the burden Asian American patients may feel are on their caregivers by designing and testing the feasibility and efficacy of a positive activity intervention designed to increase a sense of autonomy, competence, and connectedness, each of which have been shown to be associated with psychological benefits according to self-determination theory.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 21 to 80. Healthy volunteers may be eligible.
You may be able to join if
- for Patients:
- self-identifies as Asian American or Asian
- males or females ages 21-80 years
- within 2 years of any cancer diagnosis or stage 4 cancer diagnosis
- actively undergoing surgery or systemic therapy (e.g., chemotherapy, radiation, immunotherapy) or within the past 6 months,
You likely can't join if
- for patients:
- life expectancy less than 6 months in the opinion of the primary physician
- inability to stand or walk on their own or other physical limitations that preclude them from participating (3+ on ECOG performance status),
- major thought disorder (e.g., schizophrenia or bipolar [patient records or self-disclosure]). Inclusion Criteria for Caregivers:
- identifies as Asian American or Asian,
- patient considers them to be caregiver
See the full eligibility criteria
- for Patients:
- self-identifies as Asian American or Asian
- males or females ages 21-80 years
- within 2 years of any cancer diagnosis or stage 4 cancer diagnosis
- actively undergoing surgery or systemic therapy (e.g., chemotherapy, radiation, immunotherapy) or within the past 6 months,
- able to identify a caregiver (e.g., spouse) who lives in the same household or see at least 3 times per week
- able to read, write, and speak English (i.e., English proficient; EP) or Mandarin/simplified Chinese.
- for patients:
- life expectancy less than 6 months in the opinion of the primary physician
- inability to stand or walk on their own or other physical limitations that preclude them from participating (3+ on ECOG performance status),
- major thought disorder (e.g., schizophrenia or bipolar [patient records or self-disclosure]). Inclusion Criteria for Caregivers:
- identifies as Asian American or Asian,
- patient considers them to be caregiver
- English proficient or Mandarin Chinese proficient
- access to computer/phone, internet, and web browser. Exclusion Criteria for Caregivers:
- unwilling or unable to participate in the study for any reason,
- under the age of 18.
The study team makes the final eligibility decision.
Where it's taking place
- Philadelphia, Pennsylvania, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 21 years to 80 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Philadelphia, Pennsylvania, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.